Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Open-Label Single-Arm Study of Optaflu in Germany
2013-000621-30Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of influenza vaccine in influenza, sponsored by Novartis. Primary endpoints: Safety endpoints and Immunogenicity endpoints. Started Mar 2013; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2013-000621-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000621-30.